Overview
Jordan Johnson is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment. Dr. Johnson is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9821 S May Ave, Suite C, Oklahoma City, OK 73159
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Nabil Srouji is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Srouji is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy. Dr. Srouji is currently accepting new patients.
Eye Associates Of Oklahoma PLLC
Robert Leonard is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Leonard is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Retinal Vein Occlusion. Dr. Leonard is currently accepting new patients.
Eye Associates Of Oklahoma PLLC
Darin Haivala is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Haivala is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Retinal Artery Occlusion. Dr. Haivala is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyDr. Johnson isAdvanced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationDr. Johnson isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Johnson isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal DetachmentDr. Johnson isAdvanced. Learn about Retinal Detachment.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Choroid Plexus CarcinomaDr. Johnson isExperienced. Learn about Choroid Plexus Carcinoma.
- Cone DystrophyDr. Johnson isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Johnson isExperienced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Johnson isExperienced. Learn about Doyne Honeycomb Retinal Dystrophy.